The Hindu Business Line : Natco Pharma net up 12%

Hyderabad, Nov. 1 Natco Pharma Ltd’s net profit increased 12 per cent at Rs 11.87 crore in the second quarter ended September 30, 2008 compared with Rs 10.57 crore in the corresponding quarter of previous financial year.

The total revenue increased 26 per cent at Rs 114 crore (Rs 90 crore), according to a release. The growth in revenue and profit was driven by growth in the formulations business, Mr Bhaskar Narayana, Vice-President (Finance), Natco Pharma told Business Line.

The earnings per share stood at Rs 4.23 (Rs 3.77). During the quarter, Natco launched Albupax, the first generic version of the international brand Abraxane, used for the treatment of breast cancer, the release added.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Better productivity boosts Thomas Cook net

XL Telecom net soars

Kingfisher loss at Rs 483 cr

Forex loss drags Lanco Infra net down 8% at Rs 51 cr

Aurobindo Pharma posts Rs 38.50-cr loss

Natco Pharma net up 12%

Suven Life profit jumps

Elgi Equipments Q2 net down 8%

Amara Raja Q2 net falls on forex fluctuation

Unitech Q2 net declines 12% as high borrowing cost hurts margins

Parsvnath Q2 profit drops to Rs 22.8 cr

Gujarat NRE Coke promoters raise stake

Deccan Chronicle net declines